Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VETC-based Precision Adjuvant Therapy for HCC
NCT06311929Phase 4Recruiting
- Start
- Apr 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lenvatinib in hepatocellular carcinoma (HCC). Started Apr 2024; status: recruiting.
02
Drugs
lenvatinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06311929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06311929.